By Shannon Cooke, Project Manager, Life Science Solutions, TransPerfect Life Sciences
Technology continues to advance at almost breakneck speeds. Not only are these advancements surpassing anything we could have imagined just 10 or 20 years ago, they are touching every professional field, including Life Sciences. More advanced computers, displays, and software programs are replacing paper, cards, files, and binders in libraries, banks, and professional offices around the world. Yet despite a clear need and desire to move in a paperless direction, clinical trials still lag far behind other highly regulated industries.
By Ruth Garcia, Betty Howard, Rose LaRue, Glenn Parton, and John Walker, Steris Isomedix Services
A crucial step in pharmaceutical production is sterilization. There are many sterilization methods to choose from such as steam, sterile filtration, ethylene oxide gas (EtO), electron beam (E-beam), and gamma radiation. Each technique has aspects that make it suitable or unsuitable for the sterilization of a particular product.
By Dr. Laura Ciccolini, Commercial Director, Biopharma Technology Limited
There have been few instances of bioweapon use by terrorists, but the impact has been significant. With the growth of political turmoil and of extremists groups, the potential danger of bioterrorism is increasingly in the minds of the public and governments.
By Bopanna N.K., Chitra Sundararajan, and Melissa J Wilcox, Grace Discovery Sciences
Peptides and proteins are becoming increasingly popular for their potential use as therapeutic drugs. To earn and maintain a share in the fast-growing peptide market, peptide researchers and manufacturers are constantly trying to improve and optimize the various steps in peptide synthesis.
A Q&A With Christophe Couturier, VP of Services, Merck Millipore
The challenge of getting your drug product to clinical trials is expensive and time-consuming. This portion of the drug development pipeline could take an average of 18 months to complete — not to mention the sizable investment in facilities and labor. How can pharma and biopharma manufacturers keep new, innovative drugs in the pipeline and still cut down on those big risk factors?
By Gail Dutton, DASGIP Information and Process Technology GmbH, an Eppendorf company
For many bioprocessing professionals the proliferation of process monitoring and control solutions presents an immense opportunity to improve their knowledge of their mammalian cell cultivation or microbial fermentation processes.
By Nitin Dahad, Dyzle
In the cold chain logistics industry there's a huge change happening. Lots of data is being gathered by wirelessly connected data loggers, sensors, and monitoring equipment. This is sometimes referred to as real-time monitoring or "near-real-time" monitoring. Having all this information is great, and this may contribute to GDP and GMP guidelines for food and pharmaceutical industries, but having too much data may also pose challenges if not managed properly.
By Todd Keefe, Southwest Airlines Cargo
The ecosystem tied to the movement of medical and pharmaceutical products is complex and highly distributed. Shippers and receivers for these life-saving products are spread out around the country, and there are no centralized routes between them.
IBC's Biopharmaceutical Development & Production (BDP) Week event (March 24 to 27, 2014, San Diego, CA) provides the most in-depth coverage of bioprocessing methods in the field to give you the tools you need to develop and manufacture the increasingly diverse and complex molecules emerging in the biopharmaceutical pipeline. New registrations can save 20 percent off the standard rate with priority code BDP14BRO. Download the event brochure.